UNIVERSAL DISPLAY CORP (OLED)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for OLED
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OLED | Independent Director | 61 | ["Founder and Chief Executive Officer, Princeton Healthcare Advisory, LLC","Advisor, Rothschild & Co.","General Partner, Trevi Health Capital","Corporate Vice President, Head of Corporate Development and Strategy, Covance, Inc.","Over 25 years of leadership and strategy experience across public companies","Extensive M&A, strategic partnership and investment experience","Deep understanding of structuring and negotiating licensing and commercialization agreements","Regulatory and policy experience","Public company board and committee experience"] | ["Technology & Innovation (Chair)","Human Capital","Investment"] | 2026 |
Biography sourced from the proxy statement filing.
Independent Director Director since: 2024 Age: 61 Committees: Technology & Innovation (Chair), Human Capital, Investment Professional Experience Highlights Founder and Chief Executive Officer, Princeton Healthcare Advisory, LLC (2015 Present), a specialty advisory firm supporting growth-focused private equity, venture capital and strategic investors in the healthcare and life sciences sectors Advisor, Rothschild & Co., Five Arrows Managers LLP (2024 Present), the alternative assets arm of Rothschild & Co. General Partner, Trevi Health Capital (2015 2018), a healthcare focused specialty investment firm Corporate Vice President, Head of Corporate Development and Strategy, Covance, Inc. (formerly NYSE: CVD) (2006 2015) Skills and Qualifications Over 25 years of leadership and strategy experience across public companies and as an advisor to growth-focused investors, including as CEO of Princeton Healthcare Advisory Extensive M&A, strategic partnership and investment experience , having executed 25+ transactions with an aggregate value exceeding $10 billion, including the $6.2 billion sale of Covance to LabCorp (NYSE: LH), demonstrating strong deal execution and value realization capabilities Deep understanding of structuring and negotiating licensing and commercialization agreements in highly IP-driven industries , aligning closely with the Company's strategy of monetizing its technology portfolio through long-term licensing arrangements Regulatory and policy experience through advising governments, membership of industry trade association regulatory groups, and oversight of corporate regulatory affairs operations, supporting informed oversight of evolving regulatory landscapes and geopolitical considerations relevant to the Company's global operations Public company board and committee experience , including service on Inotiv, Inc. (Nasdaq: NOTV), with roles on the Audit, Compensation, and Nominating & Governance Committees, strengthening governance, oversight, and shareholder alignment Other Public Company Boards Inotiv, Inc. (Nasdaq: NOTV) (2021 Present), a contract research organization Education M.A. & D.Phil, University of Oxford M.B.A., The Open University Nestl Post-Doctoral Fellowship, Massachusetts Institute of Technology